Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 110 clinical trials
None
Total-Body Parametric 18F-FDG PET of COVID-19

The primary objective is to measure the change between COVID-19 patients and normal subjects; the secondary objective is to measure the change in COVID-19 patients between baseline and 4-month follow up.

  • 7 views
  • 18 Nov, 2021
  • 1 location
None
Prediction of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage Using Dynamic 18F-FDG PET/CT

A pilot trial for assessing early microvascular alterations after aneurysmal subarachnoid hemorrhage using dynamic 18F-FDG PET/CT. The primary endpoint will be the measure of early changes in

  • 0 views
  • 08 Jan, 2022
  • 1 location
None
Prospective Comparison of 18F-FDG and 18F-FET PET for Response Evaluation in Patients With Primary Central Nervous System Lymphoma

The overall goal of this imaging trial is to prospectively compare the usefulness of 18F-FDG PET and 18F-FET PET in evaluating treatment response and predicting prognosis in patients with

  • 0 views
  • 25 Oct, 2021
  • 1 location
None
Determination of Molecular Status as Well as the Efficacy and Safety of Fluorodeoxyglucose (18F-FDG) in PET-CT Imaging in Juvenile Patients With Histiocytosis

, monitoring its presence in free-circulating DNA, and determining the efficacy of fluorodeoxyglucose (18F-FDG) in PET-CT imaging.

  • 0 views
  • 08 Jul, 2021
  • 1 location
None
Medical Imaging of Cachexia

This is a pilot trial using 18F-FDG PET and DXA scans to determine whether these investigations are objective tools to assess cachexia.

malignant disease
sarcopenia
medical imaging
  • 0 views
  • 11 Nov, 2021
  • 1 location
None
Evaluation of PET CT in the Management of Patients With Crohn's Disease.

18F-FDG PET/CT (2-[fluorine-18] fluoro-2-deoxy-D-glucose, Positron emission tomography- CT) is a noninvasive technique that allows quantifying and precisely localizing 18F-FDG uptake in

inflammatory bowel disease
tumor necrosis factor alpha
remission
tumor necrosis factor
tumour necrosis
  • 15 views
  • 07 Nov, 2020
  • 1 location
None
Assessment of Positron Emission Tomography to Early Detect Frailty in Onco-geriatry

or indirectly with the cognitive or thymic impacts related with other components (nutritional or autonomy or walking poor status, comorbidities) 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission

  • 0 views
  • 06 Oct, 2021
  • 1 location
None
Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET

intermediate stage (HL2) disease and of an intensified etoposide-free chemotherapy regimen for patients with advanced disease (HL3) including 18F-FDG-PET evaluation.

chemotherapy regimen
nodular sclerosis
lymphoma
etoposide
classical hodgkin lymphoma
  • 1 views
  • 07 Nov, 2020
  • 1 location
None
Clinical Application of 68Ga-DOTA-NT-20.3 in the Early Diagnosis of Pancreatic Ductal Adenocarcinoma

The purpose of this study is to determine the pharmacokinetics, dosimetry, tolerance, tumor detection rate of 68Ga-DOTA-NT-20.3 in patient with pancreatic ductal adenocarcinoma (PDAC).

  • 0 views
  • 25 Sep, 2021
  • 1 location
None
PennPET Explorer Scanner Evaluation

Positron Emission Tomography (PET) is a procedure that uses a special type of machine to take pictures of the inside of the body after a radioactive drug is administered. The radioactive drug that is used for this study may be an FDA approved imaging drug or may be used as …

  • 0 views
  • 03 Feb, 2021
  • 1 location